Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02637 HAIXI PHARMA
RT Nominal up191.300 +9.000 (+4.937%)
Disclosure of Interest

20/10/2025 16:08

{New Stock}HAIXI PHARMA(02637) ends up 20.6% at HK$104.2

[ET Net News Agency, 20 October 2025] Shares of HAIXI PHARMA (02637) closed at HK$104.2in its first trading day, or 20.6% higher than its offer pri ... more View All

20/10/2025 09:21

{New Stock}HAIXI PHARMA(02637) opens up 18.06% at HK$102

[ET Net News Agency, 20 October 2025] Shares of HAIXI PHARMA (02637) opened at HK$102 in its first trading day, or 18.1% higher than its offer pri ... more View All

1

Remark: Real time quote last updated: 15/04/2026 16:28
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.